Literature DB >> 7762713

The practice of prophylactic mastectomy: a survey of Maryland surgeons.

F Houn1, K J Helzlsouer, N B Friedman, M E Stefanek.   

Abstract

OBJECTIVES: Bilateral prophylactic mastectomy is a drastic breast cancer preventive option for which indications are not standardized and efficacy has not been proven. To estimate the magnitude of this controversial practice, surgeons were surveyed on their recommendations about and performance of prophylactic mastectomy.
METHODS: A cross-sectional survey was sent to general surgeons (n = 522), plastic surgeons (n = 80), and gynecologists (n = 801) licensed to practice in Maryland in 1992. Proportions responding were 41.9%, 66.3%, and 54.9%, respectively. In addition, there were 30 respondents who identified "other" as their specialty. The respondents were asked about the role of bilateral prophylactic mastectomy and the number of times they had recommended and performed it in a year.
RESULTS: Seven hundred forty-two surgeons responded (51.8%). More plastic surgeons (84.6%) than general surgeons (47.0%) and gynecologists (38.3%) agreed that bilateral prophylactic mastectomy has a role in the care of high-risk women. Eighty-one percent of plastic surgeons had recommended the procedure, compared with 38.8% of general surgeons and 17.7% of gynecologists.
CONCLUSIONS: Indications and practice patterns reveal heterogeneity of medical opinion and practice of prophylactic mastectomy. This study raises the need for better evaluation of the efficacy and appropriateness of prophylactic mastectomy.

Entities:  

Mesh:

Year:  1995        PMID: 7762713      PMCID: PMC1615504          DOI: 10.2105/ajph.85.6.801

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  22 in total

1.  Technical considerations for prophylactic mastectomy in patients at high risk for breast cancer.

Authors:  W J Temple; R L Lindsay; E Magi; S J Urbanski
Journal:  Am J Surg       Date:  1991-04       Impact factor: 2.565

2.  Primary breast cancer after prophylactic mastectomy.

Authors:  L D Ziegler; S S Kroll
Journal:  Am J Clin Oncol       Date:  1991-10       Impact factor: 2.339

3.  Analysis of the risk reduction of prophylactic partial mastectomy in Sprague-Dawley rats with 7,12-dimethylbenzanthracene-induced breast cancer.

Authors:  J H Wong; C F Jackson; J S Swanson; M A Palmquist; A A Oyama; S H Miller; W S Fletcher
Journal:  Surgery       Date:  1986-01       Impact factor: 3.982

4.  Selective, elective, prophylactic contralateral mastectomy.

Authors:  H P Leis
Journal:  Cancer       Date:  1971-10       Impact factor: 6.860

5.  Geographic variation in the treatment of localized breast cancer.

Authors:  D C Farrow; W C Hunt; J M Samet
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

6.  Breast cancer risk factors: can we select women for prophylactic mastectomy?

Authors:  M T Schechter
Journal:  Can J Surg       Date:  1985-05       Impact factor: 2.089

Review 7.  A reappraisal of prophylactic mastectomy.

Authors:  I L Wapnir; B Rabinowitz; R S Greco
Journal:  Surg Gynecol Obstet       Date:  1990-08

8.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

9.  Prophylactic mastectomy: pros and cons.

Authors:  R K Snyderman
Journal:  Cancer       Date:  1984-02-01       Impact factor: 6.860

10.  Prophylactic mastectomy for precancerous and high-risk lesions of the breast.

Authors:  S Ariyan
Journal:  Can J Surg       Date:  1985-05       Impact factor: 2.089

View more
  7 in total

1.  Commercialization of BRCA1/2 testing: practitioner awareness and use of a new genetic test.

Authors:  M K Cho; P Sankar; P R Wolpe; L Godmilow
Journal:  Am J Med Genet       Date:  1999-03-19

2.  Significant differences among physician specialties in management recommendations of BRCA1 mutation carriers.

Authors:  S U Dhar; H P Cooper; T Wang; B Parks; S A Staggs; S Hilsenbeck; S E Plon
Journal:  Breast Cancer Res Treat       Date:  2011-04-05       Impact factor: 4.872

3.  The process of deciding about prophylactic surgery for breast and ovarian cancer: Patient questions, uncertainties, and communication.

Authors:  Robert Klitzman; Wendy Chung
Journal:  Am J Med Genet A       Date:  2010-01       Impact factor: 2.802

4.  Do physicians tailor their recommendations for breast cancer risk reduction based on patient's risk?

Authors:  Jennifer S Haas; Celia P Kaplan; Steven E Gregorich; Eliseo J Pérez-Stable; Genevieve Des Jarlais
Journal:  J Gen Intern Med       Date:  2004-04       Impact factor: 5.128

5.  International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.

Authors:  Kelly A Metcalfe; Daphna Birenbaum-Carmeli; Jan Lubinski; Jacek Gronwald; Henry Lynch; Pal Moller; Parviz Ghadirian; William D Foulkes; Jan Klijn; Eitan Friedman; Charmaine Kim-Sing; Peter Ainsworth; Barry Rosen; Susan Domchek; Teresa Wagner; Nadine Tung; Siranoush Manoukian; Fergus Couch; Ping Sun; Steven A Narod
Journal:  Int J Cancer       Date:  2008-05-01       Impact factor: 7.396

Review 6.  Risk-reducing mastectomy for the prevention of primary breast cancer.

Authors:  Nora E Carbine; Liz Lostumbo; Judi Wallace; Henry Ko
Journal:  Cochrane Database Syst Rev       Date:  2018-04-05

7.  Variation in rates of uptake of preventive options by Canadian women carrying the BRCA1 or BRCA2 genetic mutation.

Authors:  Kelly A Metcalfe; Parviz Ghadirian; Barry Rosen; William Foulkes; Charmaine Kim-Sing; Andrea Eisen; Peter Ainsworth; Doug Horsman; Christine Maugard; Diane Provencher; André Robideaux; Dawna Gilchrist; Albert Chudley; Edmond G Lemire; Susan Armel; Amy Finch; Ping Sun; Steven A Narod
Journal:  Open Med       Date:  2007-08-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.